Micro-Surgical Robot Market Research Report and Outlook by 2028

The global market for micro-surgical robots is projected to expand significantly, increasing from approximately US$ 1,280.81 million in 2022 to around US$ 2,817.57 million by 2028. This growth represents a compound annual growth rate (CAGR) of 11.9% over the forecast period from 2022 to 2028.

The surge in demand for minimally invasive surgical techniques, coupled with the numerous benefits associated with robotic surgeries?such as enhanced precision, consistency, control, and operational efficiency?are key factors driving the expansion of the micro-surgical robot market.

Robotic surgery has emerged as a groundbreaking innovation in the field of liposuction. In this procedure, a surgeon operates from a master console while a robotic patient cart executes the surgical tasks with greater ease and precision compared to traditional laparoscopic methods. The advantages of robotic surgery in liposuction include superior 3D visualization, enhanced accuracy, and intuitive multi-range instruments, all of which contribute to improved patient safety. Furthermore, robotic systems enhance suturing capabilities and help minimize post-operative discomfort and recovery times. For patients with obesity, particularly those exceeding 250 kg, robot-assisted liposuction is often preferred due to the complexities associated with laparoscopic techniques.

A study titled "Comparison of surgical outcomes between integrated robotic and conventional laparoscopic surgery for distal gastrectomy: a propensity score matching analysis," published in 2020, highlighted that the surgical success rate for the integrated robotic distal gastrectomy (IRDG) group was an impressive 98%, significantly surpassing the 89.5% success rate of the conventional laparoscopic distal gastrectomy (CLDG) group. While both groups exhibited comparable rates of in-patient and out-patient complications, the IRDG group experienced a notably lower readmission rate. Additionally, robotic surgeries provide enhanced visualization, allowing surgeons to observe intricate details through high-definition cameras. These robotic systems possess greater dexterity than the human hand, enabling them to rotate 360 degrees and navigate challenging anatomical areas.

Researchers have innovatively integrated a nitrogen-powered arm, serving as a fifth robotic arm, with an optical magnification video lens system (Point-Setter arm and VITOM lens from Karl Storz, Tuttlingen, Germany) to create a robotic platform for extracorporeal microsurgical procedures. The VITOM system is an HD exoscopic video system equipped with optical lenses suitable for spine and pediatric surgeries, offering magnification ranging from 16x to 25x. Surgeons can view images from the VITOM system directly beneath the primary 3D camera feed using the TilePro imaging software, thereby enhancing the accuracy and efficiency of robotic microsurgeries.

Micro-surgical robots have also played a crucial role in mitigating the spread of COVID-19 by providing a protective barrier for healthcare professionals. Prominent Indian medical institutions, including Tata Memorial, Apollo Hospitals, Rajiv Gandhi Cancer Institute, and Manipal Hospitals, have adopted micro-surgical robots to address the backlog of elective surgeries that were postponed during the pandemic's early stages, thereby reducing infection risks for both patients and healthcare workers. Organizations such as SAGE and the Associations of Robotic Consortium have explored innovative surgical methods during the recovery phase from the pandemic, comparing traditional surgical techniques with robotic-assisted surgeries. Robotic-assisted surgery (RAS) typically requires only four devices and a small medical team, resulting in less invasive procedures that minimize pain and blood loss. Patients benefit from quicker recovery times, allowing for earlier discharge from medical facilities. Additionally, robotic surgeries enable surgeons to perform multiple operations in a day without experiencing fatigue, as the procedures are conducted by robotic arms controlled from a remote console, providing a magnified 3D view of the surgical field.

In response to the challenges posed by the COVID-19 pandemic, government initiatives and investments in medical robotics have seen a notable increase. In August 2020, Medicaroid became the first Japanese company to receive approval from the health ministry to manufacture and market a robotic-assisted surgical system. The number of da Vinci systems in Chinese hospitals rose from 8 in 2018 to 59 in 2019, reflecting the success of Intuitive Surgical's joint venture. By the end of 2020, the Chinese central government had acquired over 150 surgical robotic systems. Furthermore, the Thailand Board of Investment established a committee in early 2021 to foster innovation in medical robotics technology.

From a component perspective, the global micro-surgical robot market is divided into instruments and accessories, with the instruments segment anticipated to hold a larger market share in 2022. This segment is also projected to experience a faster CAGR during the forecast period.

In terms of application, the market is categorized into plastic reconstructive surgery, ENT surgery, urology surgery, neurosurgery, ophthalmic surgery, lymphatic surgery, and others. The urology surgery segment is expected to dominate the market in 2022 and is forecasted to achieve the highest CAGR from 2022 to 2028.

Regarding end users, the market is segmented into hospitals & clinics, ambulatory surgical centers, research institutes, and others. The hospitals & clinics segment is projected to account for the largest market share in 2022 and is also expected to register the highest CAGR from 2022 to 2028, driven by the increasing number of surgical procedures and the adoption of advanced technologies in these facilities.

Key sources utilized in the preparation of the report on the global micro-surgical robot market include the Agency for Healthcare Research and Quality, World Health Organization (WHO), Brain Tumour Registry of Canada, Central Intelligence Agency, Universidad Aut?noma de Nuevo Le?n, Canadian Institute of Health Information, Centers for Disease Control and Prevention (CDC), National Statistics Institute (INE), and the Organization for Economic Co-operation and Development (OECD).